Arena Pharma (ARNA) Tops Q3 EPS by 2c

November 7, 2016 4:34 PM EST

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $19 million versus the consensus estimate of $13.99 million.

For earnings history and earnings-related data on Arena Pharma (ARNA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment